Science Explorer Back to mapMap
Discussion
Researcher · Integra (United States) · United States

Lindsay Aton

Lindsay Aton publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Genetics, on topics such as Advanced Breast Cancer Therapies, Chronic Lymphocytic Leukemia Research and PARP inhibition in cancer therapy.

OpenAlex
World rank
#5,492,229
of 7,710,434 ranked researchers
Rank in United States
#1,384,646
of 1,627,098
Works
15
Citations
25
Citations per work
1.7
h-index
3
i10-index 0Top 97% in Oncology
Lindsay Aton

What does Lindsay Aton research?

Lindsay Aton's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (14%).

Health Sciences: 10 works · 69.4% of their workMedicine: 10 works · 69.4% of their workOncology: 4 works · 27.8% of their workPulmonary and Respiratory Medicine: 3 works · 19.4% of their workGenetics: 2 works · 13.9% of their workHematology: 1 works · 8.3% of their workEverything else: 3 works · 16.7% of their workLife Sciences: 2 works · 13.9% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 13.9% of their workCancer Research: 1 works · 8.3% of their workGenetics: 1 works · 5.6% of their workTHEIR WORKLindsay Aton15works
Life Sciences14%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1069.4%
  2. Everything else316.7%
    1. Biochemistry, Genetics and Molecular Biology213.9%
  1. 1Oncology28% of their works
  2. 2Pulmonary and Respiratory Medicine19% of their works
  3. 3Genetics14% of their works
  4. 4Cancer Research8% of their works
  5. 5Hematology8% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Lindsay Aton's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, CDK4/6 Inhibitors, Palbociclib, BRCA Mutation, Chronic Lymphocytic Leukemia, Genomic Aberrations and PARP Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Breast Cancer62 topics
  2. Metastatic Breast Cancer62 topics
  3. CDK4/6 Inhibitors41 topic
  4. Palbociclib41 topic
  5. BRCA Mutation31 topic
  6. Chronic Lymphocytic Leukemia31 topic
  7. Genomic Aberrations31 topic
  8. PARP Inhibitors31 topic
  9. BCR-ABL21 topic
  10. Cancer Genomics21 topic
  11. Chemotherapy-Induced Peripheral Neuropathy21 topic
  12. HER221 topic
  13. Imatinib21 topic
  14. JAK2 Mutation21 topic
  15. Mutational Signatures21 topic
  16. Myelofibrosis21 topic
  17. Taxanes21 topic
  18. Trastuzumab21 topic

Where does Lindsay Aton work?

Lindsay Aton's main affiliation in the publication record is Integra (United States), United States.

How many publications and citations does Lindsay Aton have?

OpenAlex counts 15 works and 25 citations for Lindsay Aton, an h-index of 3, ranking #5,492,229 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lindsay Aton. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.